NAMS (NEWAMSTERDAM PHARMA COMPANY) Institutional Ownership Summary
Based on the latest SEC 13F filings, 5 institutional investors hold NAMS (NEWAMSTERDAM PHARMA COMPANY) with a combined value of $322.46M across 9,192,039 shares. The largest holder is VIKING GLOBAL INVESTORS LP with a position worth $147.46M (0.39% of their portfolio). 3 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$322.46M
Total Shares Held
9,192,039
Institutional Holders
5
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VIKING GLOBAL INVESTORS LP | $147.46M | 0.39% | -35.1% |
| 2 | Duquesne Family Office LLC | $107.70M | 2.40% | +59.6% |
| 3 | BlackRock, Inc. | $29.81M | 0.00% | +36.5% |
| 4 | CITADEL ADVISORS LLC | $26.29M | 0.00% | +162.9% |
| 5 | Slate Path Capital LP | $11.19M | 0.15% | - |